Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11227 publications

Plasma N-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD.

Plasma N-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 16, 2025

Assessment of IL-17 in multiple sclerosis and its relationship with disease severity in Egypt.

Assessment of IL-17 in multiple sclerosis and its relationship with disease severity in Egypt.

Journal: The Egyptian journal of immunology
Published: October 14, 2025

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis.

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 08, 2025

Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy.

Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy.

Journal: Neurodegenerative disease management
Published: October 07, 2025

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

Journal: Annals of agricultural and environmental medicine : AAEM
Published: September 30, 2025

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Journal: Radiology
Published: September 30, 2025

Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.

Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.

Journal: Neurology
Published: September 29, 2025

Multiple sclerosis updates and the safety and efficacy of Bruton tyrosine kinase inhibitors in it: A systematic review.

Multiple sclerosis updates and the safety and efficacy of Bruton tyrosine kinase inhibitors in it: A systematic review.

Journal: Disease-a-month : DM
Published: September 27, 2025

FCRL5, a B-Cell Marker With Novel Diagnostic and Prognostic Value for Multiple Sclerosis.

FCRL5, a B-Cell Marker With Novel Diagnostic and Prognostic Value for Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 26, 2025

Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.

Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.

Journal: Neurology
Published: September 22, 2025

Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.

Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 19, 2025

Angiogenesis and Hypoxia Biomarkers Are Dysregulated in Progressive Multiple Sclerosis.

Angiogenesis and Hypoxia Biomarkers Are Dysregulated in Progressive Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 18, 2025
Showing 1-12 of 11,227

Last Updated: 10/31/2025